ÂÜÀòÂÒÂ×

Emily Marden serves as Senior Counsel in the Food and Drug Regulatory group at Sidley Austin LLP since September 2013, specializing in a broad range of regulatory issues, including cell and gene therapy and biological product approvals. As an Adjunct Professor of Law at New York University School of Law, Emily co-teaches courses on Food and Drug Law and Policy. Additionally, Emily holds the position of Research Associate at The University of British Columbia, focusing on international treaties related to agricultural genomics research. Previous roles include Senior Legal Counsel at QLT Inc., Senior Corporate Counsel at Pfizer, and Associate at Sidley Austin LLP. Emily's educational background includes a Doctor of Law (J.D.) from New York University School of Law and advanced degrees from Harvard University and the University of Cambridge in related fields.